Get started
Author

D. V. Fedyaev

New Approaches to the Development of Diagnostic Related Groups for Cancer Pharmacotherapy in Russian Federation
2018 · M. V. Avxentyeva, V. V. Omelyanovskiy, et al. · Medical Technologies Assessment and Choice · 19
Changes in diagnosis-related group payment model in the Russian Federation in 2024
2024 · E.I. Rumyantseva, I.A. Zheleznyakova, et al. · Medical Technologies Assessment and Choice · 12
Incidence of proximal femur fractures in patients aged 60 years and older in the Russian Federation
2020 · Yu.V. Seryapina, D.V. Fedyaev, et al. · Medical Technologies Assessment and Choice · 11
Main changes in payment model for diagnosis-related groups in the Russian Federation in 2023
2023 · O.S. Plakhotnik, G.V. Trifonova, et al. · Medical Technologies Assessment and Choice · 9
Main Changes in the Model of Diagnosis-Related Groups in Russia in 2020
2020 · Maria Leonidovna Lazareva, Inna Alexandrovna Zheleznyakova, et al. · Medical Technologies Assessment and Choice · 9
Changes in diagnosis-related group payment model in the Russian Federation in 2025
2025 · I.A. Zheleznyakova, O.S. Plakhotnik, et al. · Medical Technologies Assessment and Choice · 8
Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan
2019 · T. P. Bezdenezhnykh, D. V. Fedyaev, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 8
PDF
Main changes in the model of diagnosis-related groups in 2021
2021 · V.V. Omelyanovskiy, M.V. Avxentyeva, et al. · Medical Technologies Assessment and Choice · 7
Analysis of demographic, social and economic impacts of proximal femur fracture's surgical treatment for geriatric patients in Russia
2021 · Yu. V. Seryapina, D. V. Fedyaev, et al. · Russian Journal of Geriatric Medicine · 5
PDF
Provision of free medical care in Russia and elsewhere: review of regulatory and legal aspects
2017 · A. N. Daikhes, D. V. Fedyaev · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 5
Cost-effectiveness Analysis of Brentuximab Vedotin in Adults With Relapsed or Refractory Hodgkin’s Lymphoma
2016 · G. R. Khachatryan, D. V. Fedyaev, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 5
PDF
Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access
2024 · I. A. Zheleznyakova, O. A. Volkova, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 4
Improving the model of payment for medical care for infertility using assisted reproductive technologies in the program of state guarantees of free medical care to citizens for 2023 and 2024—2025
2023 · I.A. Zheleznyakova, O.A. Volkova, et al. · Medical Technologies Assessment and Choice · 4
PDF
Key business processes in healthcare and their readiness for digital transformation
2022 · L.D. Pestrenin, Yu.V. Seryapina, et al. · Medical Technologies Assessment and Choice · 4
Review of foreign experience in the implementation of eHealth
2021 · P. V. Minaev, D. V. Fedyaev, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 4
PDF
Continuity of outpatient and inpatient drug supply of cancer patients — problems and solutions
2021 · Yu.A. Agafonova, D.V. Fedyaev, et al. · Medical Technologies Assessment and Choice · 4
Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
2019 · F. V. Gorkavenko, A. V. Nikitina, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 4
PDF
A methodology for analyzing the regional medical care payment system in the framework of a model of clinical and statistical groups
2018 · D. V. Fedyaev, M. L. Lazareva, et al. · Russian Journal of Preventive Medicine · 4
Cost-Effectiveness Analysis of Different Biologic Agents For Ankylosing Spondylitis Treatment In Russia
2016 · D Fedyaev, EV Derkach · Value in Health · 4
Standardized methodology for calculating the cost of medical care funded by government sources
2025 · M. A. Sdvizhkova, S. A. Kovaleva, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 3
PDF
Analysis of tariff agreements of the constituent entities of the Russian Federation: form and completeness of data presentation
2023 · D. V. Fedyaev, F. S. Nikitin, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 3
PDF
The review of the foreign experience on the financing of innovative medical technologies
2020 · V. V. Omelyanovskiy, I. A. Zheleznyakova, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 3
PDF
Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation
2020 · A. V. Nikitina, F. V. Gorkavenko, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 3
PDF
Overview of the existing opportunities and limitations of the state guarantees program for provision of free medical care to citizens
2019 · D. V. Fedyaev, R. V. Gostishchev, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 3
Comparative Pharmacoeconomic Evaluation of the Use of Afatinib and Gefitinib in Therapy for Lung Cancer
2017 · Denis Fedyaev, V. Ignateva, et al. · Voprosy Onkologii · 3
PDF
Works count: 57
Citation count: 178
H-index: 7
I10-index: 3
Year
Topic
Type